Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer
Clinical trial NCT04750239 · TERMINATED
Trial details
- NCT number
- NCT04750239
- Sponsor
- Y-mAbs Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-17
- Primary completion
- 2022-04-08
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.